California-based Cytek Biosciences Inc. has pocketed $120 million in a Series D round funding co-led by the US investment manager RA Capital and the Asia focused private equity firm Hillhouse Capital, per a company statement on Friday.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
